Home Healthcare Pharmaceuticals Cryptococcosis Market

Cryptococcosis Market Size, Share & Trends Analysis Report By Treatment (Amphotericin B, Flucytosine, Fluconazole, Corticosteroids, Itraconazole, Cryptococcomas), By Species Type (Cryptococcus Neoformans, Cryptococcus Gattii) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: October 13, 2026 | Author: Straits Research Team | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Cryptococcosis Market, By Treatment 2025-2034 (USD MILLION/ Units)
    1. Amphotericin B
    2. Flucytosine
    3. Fluconazole
    4. Corticosteroids
    5. Itraconazole
    6. Cryptococcomas
  2. Cryptococcosis Market, By Species Type 2025-2034 (USD MILLION/ Units)
    1. Cryptococcus Neoformans
    2. Cryptococcus Gattii
  3. Regional Cryptococcosis Market
    1. North America
      1. North America Cryptococcosis Market By Treatment 2025-2034 (USD MILLION/ Units)
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
      2. North America Cryptococcosis Market By Species Type 2025-2034 (USD MILLION/ Units)
        1. Cryptococcus Neoformans
        2. Cryptococcus Gattii
      3. U.S.
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
      4. Canada
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
    2. Europe
      1. Europe Cryptococcosis Market By Treatment 2025-2034 (USD MILLION/ Units)
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
      2. Europe Cryptococcosis Market By Species Type 2025-2034 (USD MILLION/ Units)
        1. Cryptococcus Neoformans
        2. Cryptococcus Gattii
      3. U.K.
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
      4. Germany
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
      5. France
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
      6. Spain
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
      7. Italy
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
      8. Russia
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
      9. Nordic
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
      10. Benelux
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
      11. Rest of Europe
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
    3. APAC
      1. APAC Cryptococcosis Market By Treatment 2025-2034 (USD MILLION/ Units)
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
      2. APAC Cryptococcosis Market By Species Type 2025-2034 (USD MILLION/ Units)
        1. Cryptococcus Neoformans
        2. Cryptococcus Gattii
      3. China
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
      4. Korea
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
      5. Japan
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
      6. India
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
      7. Australia
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
      8. Taiwan
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
      9. South East Asia
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
      10. Rest of Asia-Pacific
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
    4. Middle East and Africa
      1. Middle East and Africa Cryptococcosis Market By Treatment 2025-2034 (USD MILLION/ Units)
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
      2. Middle East and Africa Cryptococcosis Market By Species Type 2025-2034 (USD MILLION/ Units)
        1. Cryptococcus Neoformans
        2. Cryptococcus Gattii
      3. UAE
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
      4. Turkey
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
      5. Saudi Arabia
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
      6. South Africa
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
      7. Egypt
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
      8. Nigeria
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
      9. Rest of MEA
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
    5. LATAM
      1. LATAM Cryptococcosis Market By Treatment 2025-2034 (USD MILLION/ Units)
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
      2. LATAM Cryptococcosis Market By Species Type 2025-2034 (USD MILLION/ Units)
        1. Cryptococcus Neoformans
        2. Cryptococcus Gattii
      3. Brazil
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
      4. Mexico
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
      5. Argentina
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
      6. Chile
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
      7. Colombia
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
      8. Rest of LATAM
        1. Amphotericin B
        2. Flucytosine
        3. Fluconazole
        4. Corticosteroids
        5. Itraconazole
        6. Cryptococcomas
        7. Cryptococcus Neoformans
        8. Cryptococcus Gattii
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.